Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of February 2021. The report serves as a transaction notification regarding insider trading activity rather than a periodic financial performance report.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the transaction price of American Depositary Shares (ADSs) at $34.5350.
Material Changes
No material changes to the company's financial position or operations are reported in this document. The filing details a single transaction executed by a Person Discharging Managerial Responsibilities (PDMR).
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It strictly reports a purchase transaction.
Important Facts for Investors
- Transaction Type: Purchase of 3,400 American Depositary Shares (ADSs).
- Insider Involved: Ms. D Conrad, Senior Vice President of Human Resources.
- Transaction Date: February 19, 2021.
- Transaction Price: $34.5350 per ADS.
- Exchange: New York Stock Exchange (XNYS).
- Financial Data: No revenue, earnings, or balance sheet data is included in this specific filing.